SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-019594
Filing Date
2023-10-20
Accepted
2023-10-20 12:23:02
Documents
1
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 3004
  Complete submission text file 0001062993-23-019594.txt   4411
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 49 OLD BEAR BROOK ROAD PRINCETON NJ 08540
Business Address
Kottayil George (Reporting) CIK: 0001895357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 231336561